Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRMA | AMGN | BMY | GILD | VRTX |
| Company | Dermata Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.7398 | 271.17 | 50.26 | 78.11 | 354.00 |
| High | 0.7800 | 271.97 | 50.54 | 79.24 | 354.35 |
| Low | 0.7301 | 268.82 | 50.09 | 77.94 | 348.46 |
| Last | 0.7601 | 269.12 | 50.31 | 79.02 | 350.15 |
| Change | +0.0145 | -2.19 | +0.15 | +0.97 | -3.80 |
| % Change | +1.94% | -0.81% | +0.30% | +1.24% | -1.07% |
| Volume | 57,500 | 2,608,200 | 10,123,000 | 6,568,900 | 1,394,500 |
| 20-Day Average Volume | 603,570 | 2,110,350 | 13,721,670 | 6,205,425 | 1,462,375 |
| Previous Close | 0.7456 | 271.31 | 50.16 | 78.05 | 353.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7129 | 268.07 | 49.89 | 76.25 | 354.99 |
| 20-Day Raw Stochastic | 48.04% | 61.04% | 59.00% | 81.26% | 20.79% |
| 20-Day Relative Strength | 49.99% | 50.84% | 42.26% | 56.16% | 45.23% |
| Weighted Alpha | -83.12 | +2.80 | -37.10 | -7.30 | +11.20 |
| Today's Opinion | 72% Sell | 56% Buy | 88% Sell | Hold | 8% Sell |
| Previous Opinion | 88% Sell | 72% Buy | 88% Sell | 32% Sell | 24% Buy |
| Last Month's Opinion | 88% Sell | 72% Buy | 100% Sell | 24% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.69% since 12/01/23 | -1.22% since 12/01/23 | +0.42% since 12/01/23 | +1.76% since 12/01/23 | -0.29% since 12/01/23 |
| Low | 0.7000 on 12/04/23 | 266.63 on 12/07/23 | 49.56 on 12/05/23 | 77.16 on 12/04/23 | 347.51 on 12/04/23 |
| High | 0.7800 on 12/08/23 | 273.43 on 12/04/23 | 51.00 on 12/07/23 | 80.18 on 12/06/23 | 356.33 on 12/06/23 |
| 1-Month | |||||
| %Chg | +5.53% since 11/08/23 | -1.52% since 11/08/23 | -4.03% since 11/08/23 | +1.44% since 11/08/23 | -7.11% since 11/08/23 |
| Low | 0.5614 on 11/13/23 | 260.52 on 11/21/23 | 48.25 on 11/30/23 | 73.99 on 11/16/23 | 341.90 on 11/16/23 |
| High | 0.9750 on 11/16/23 | 274.61 on 11/15/23 | 52.57 on 11/09/23 | 80.18 on 12/06/23 | 381.59 on 11/14/23 |
| 3-Month | |||||
| %Chg | -30.90% since 09/08/23 | +3.74% since 09/08/23 | -17.28% since 09/08/23 | +3.97% since 09/08/23 | +2.07% since 09/08/23 |
| Low | 0.5614 on 11/13/23 | 249.70 on 10/31/23 | 48.25 on 11/30/23 | 72.87 on 10/03/23 | 341.85 on 10/03/23 |
| High | 1.1700 on 09/18/23 | 288.46 on 10/13/23 | 61.42 on 09/11/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| 6-Month | |||||
| %Chg | -60.20% since 06/08/23 | +21.91% since 06/08/23 | -22.97% since 06/08/23 | +0.79% since 06/08/23 | +5.28% since 06/08/23 |
| Low | 0.5614 on 11/13/23 | 215.32 on 06/12/23 | 48.25 on 11/30/23 | 72.87 on 10/03/23 | 328.61 on 06/09/23 |
| High | 2.0200 on 06/22/23 | 288.46 on 10/13/23 | 66.38 on 06/21/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,378 | 145,199,136 | 102,063,456 | 97,253,584 | 91,206,912 |
| Shares Outstanding, K | 3,189 | 535,178 | 2,034,758 | 1,246,042 | 257,683 |
| Annual Sales | 0 | 26,323,000,000 | 46,159,000,000 | 27,281,000,000 | 8,930,700,000 |
| Annual Net Income | -9,610,000 | 6,552,000,000 | 6,327,000,000 | 4,592,000,000 | 3,322,000,000 |
| Last Quarter Sales | 0 | 6,903,000,000 | 10,966,000,000 | 7,051,000,000 | 2,483,500,000 |
| Last Quarter Net Income | -1,720,000 | 1,730,000,000 | 1,928,000,000 | 2,180,000,000 | 1,035,300,000 |
| 60-Month Beta | 0.91 | 0.58 | 0.34 | 0.29 | 0.42 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 11/09/23 | 4.96 on 10/31/23 | 2.00 on 10/26/23 | 2.29 on 11/07/23 | 4.08 on 11/06/23 |
| Latest Earnings Date | 11/09/23 | 01/30/24 | 10/26/23 | 11/07/23 | 11/06/23 |
| Most Recent Dividend | N/A | 2.130 on 11/16/23 | 0.570 on 10/05/23 | 0.750 on 09/14/23 | N/A |
| Next Ex-Dividends Date | N/A | 11/16/23 | 10/05/23 | 12/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 6.55 | 11.90 | 26.78 |
